Venetoclax in Patients With MDS or AML in Relapse After AHSCT
Clinical trial NCT05226455 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05226455
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-23
- Primary completion
- 2026-11-15
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.